AACR 2022: An AI model may predict elevated pancreatic cancer risk using electronic health records
An artificial intelligence (AI) model trained using sequential health information derived from electronic health records…
Browsing: AACR
AACR 2022: KRAS G12C inhibitor sotorasib may offer long-term clinical benefit in patients with non-small cell lung cancer
Patients with non-small cell lung cancer (NSCLC) treated with the KRAS G12C inhibitor sotorasib (Lumakras)…
AACR 2022: AURORA study identifies molecular features tied to breast cancer tumour spread
Susana Garcia-Recio, PhD, a research associate in the lab of Charles M. Perou, PhD, at…
AACR 2022: Novel COVID-19 vaccine may provide protection for cancer patients with B-cell deficiencies
CoVac-1, a new vaccine against SARS-CoV-2, induced T-cell immune responses in 93 percent of patients…
AACR 2022: Lung cancer patients with a genetic variant linked to autoimmune disease may respond better to immunotherapy
A variant of the CTLA-4 gene associated with autoimmune disease was found to be more…
AACR 2022: Accounting for genetic factors that cause normal variations in PSA levels may improve the accuracy of prostate cancer detection
The accuracy of prostate-specific antigen (PSA) screening for prostate cancer could be improved by accounting…
AACR 2022: Leukaemia patients with certain gene regulation patterns may be less likely to respond to CAR T therapy
Acute lymphoblastic leukaemia (ALL) cells from patients whose cancers did not respond to CD19-targeted CAR…
AACR 2022: Characterisation and functional analysis of microbiome in cancer
During the American Association for Cancer Research (AACR) Annual Meeting 2022 on April 8-13, 2022, researchers…
AACR 2021: Neoadjuvant nivolumab plus chemotherapy increased pathological complete response rate in CheckMate-816 lung cancer trial
Adding nivolumab to chemotherapy as neoadjuvant treatment for patients with resectable non-small cell lung cancer…
AACR 2021: Unselected autologous tumour infiltrating lymphocyte therapy shows early promise in patients with metastatic melanoma
Treatment with unselected autologous tumour infiltrating lymphocytes (TILs) showed early clinical efficacy among patients with…